Clinical trial
SuperDEX Trial (Comparison of Two Doses of Dexamethasone for Malignant Spinal…
NCT00193869 · Trans Tasman Radiation Oncology Group, Other · Completed
Key facts
| NCT number | NCT00193869 |
|---|---|
| Title | SuperDEX Trial (Comparison of Two Doses of Dexamethasone for Malignant Spinal Cord Compression Treated by Radiotherapy). |
| Official title | A Pilot Randomised Comparison of Dexamethasone 96 mg Versus 16 mg Per Day for Malignant Spinal Cord Compression Treated by Radiotherapy |
| Lead sponsor | Trans Tasman Radiation Oncology Group, Other |
| Collaborators | Cancer Council New South Wales |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Spinal Cord Compression From Neoplasm Metastasis |
| Intervention type | Drug |
| Interventions | Dexamethasone |
| Enrollment | 20 |
| Start date | Sep 1, 2001 |
| Completion | Dec 1, 2003 |
| First posted | Sep 19, 2005 |
| Last update posted | May 10, 2007 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: